Troy; Carol M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Troy; Carol M..The latest application filed is for "high concentration cell penetrating caspase inhibitor conjugates, compositions and methods thereof".

Company Profile

3.6.17

Troy; Carol M. - Hastings-on-Hudson NY
TROY, CAROL M. - HASTINGS-ON-HUD NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Concentration Cell Penetrating Caspase Inhibitor Conjugates, Compositions And Methods Thereof App 20220265767 - Troy; Carol M. ; et al.	2022-08-25
Compositions And Methods For Preventing Or Reducing Inflammation By Inhibiting Caspase-9 App 20220118101 - TROY; Carol M. ; et al.	2022-04-21
Intranasal Delivery of Cell Permeant Therapeutics App 20200164026 - Troy; Carol M. ; et al.	2020-05-28
Ocular Delivery Of Cell Permeant Therapeutics For The Treatment Of Retinal Edema App 20190142915 - Troy; Carol M. ; et al.	2019-05-16
Peptide Inhibitors Of Caspase 2 Activation App 20170145055 - TROY; CAROL M.	2017-05-25
Peptide inhibitors of caspase 2 activation Grant 9,376,466 - Troy June 28, 2	2016-06-28
Intranasal Delivery Of Cell Permeant Therapeutics For The Treatment Of Edema App 20150165061 - Troy; Carol M. ; et al.	2015-06-18
Peptide Inhibitors of Caspase 2 Activation App 20150148302 - Troy; Carol M.	2015-05-28
Intranasal Delivery Of Cell Permeant Therapeutics App 20140024597 - Troy; Carol M. ; et al.	2014-01-23
Delivery Of Double-Stranded RNA Into The Central Nervous System App 20090280058 - Troy; Carol M. ; et al.	2009-11-12
Antisense compounds which prevent cell death and uses thereof Grant 7,223,856 - Troy , et al. May 29, 2	2007-05-29
Compounds which prevent neuronal cell death and uses thereof Grant 7,125,956 - Troy October 24, 2	2006-10-24
Systems and methods for silencing expression of a gene in a cell and uses thereof App 20060178297 - Troy; Carol M. ; et al.	2006-08-10
Complex for facilitating delivery of dsRNA into a cell and uses thereof App 20050260756 - Troy, Carol M. ; et al.	2005-11-24
Compounds which prevent neuronal cell death and uses thereof App 20050059603 - Troy, Carol M.	2005-03-17
Antisense oligonucleotides and related methods for regulating cell death App 20040254136 - Troy, Carol M. ; et al.	2004-12-16
Methods for preventing or inhibiting neuronal cell death Grant 6,794,126 - Troy September 21, 2	2004-09-21
Complex for facilitating delivery of dsRNA into a cell and uses thereof App 20040147027 - Troy, Carol M. ; et al.	2004-07-29
Compounds which prevent neuronal cell death and uses thereof Grant 6,635,738 - Troy October 21, 2	2003-10-21
Compounds Which Prevent Neuronal Cell Death And Uses Thereof App 20030099638 - TROY, CAROL M.	2003-05-29
Antisense compounds which prevent cell death and uses thereof App 20030092659 - Troy, Carol M. ; et al.	2003-05-15
Methods For Preventing Or Inhibiting Neuronal Cell Death App 20020044931 - TROY, CAROL M.	2002-04-18
Antisense compounds which prevent cell death and uses thereof Grant 5,929,042 - Troy , et al. July 27, 1	1999-07-27

Company Registrations

NCAGE Code	44EC5	TROY CAROL M
CAGE Code	44EC5	TROY, CAROL M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.